Target intelligence / Profile preview

Stromal antigen 1 (STAG1) (SA1)

Target
SA1
Molecular classification
Cohesin complex subunit, Structural maintenance of chromosomes (SMC) family, Scaffold/adaptor protein, Chromatin/chromosome structuring protein, Other: not a receptor, enzyme, or transporter
01

Overview

Stromal antigen 1 (STAG1) encodes a nuclear protein and core subunit of the cohesin complex, a multisubunit structure (together with SMC1, SMC3, and RAD21) that ensures proper sister chromatid cohesion from DNA replication through mitosis. STAG1 is indispensable for genome organization, participating in chromatin looping, gene regulation, and telomere stability. It physically interacts with regulatory proteins like CTCF to demarcate chromatin domains and supports the structural architecture necessary for accurate chromosome segregation and transcriptional control. Pathogenic variants in STAG1 are associated with a spectrum of developmental disorders termed cohesinopathies, marked by intellectual disability, growth delays, and congenital anomalies. Somatic STAG1 loss in cancer (particularly when STAG2 is mutated) creates vulnerabilities that can be exploited therapeutically through synthetic lethality. Although no approved drugs directly target STAG1, it remains a significant research focus in developmental biology and cancer therapeutics.

Other names
SA1SCC3AMRD47STAG1_HUMAN
02

Mechanism of action

Synthetic lethality: Inhibition of STAG1 can induce cell death in STAG2-deficient tumor cells by exacerbating sister chromatid cohesion defects, leading to mitotic failure

03

Biological functions

Sister chromatid cohesionChromosome architecture/organizationRegulation of chromatin loopingDNA repairChromosome condensationTranscriptional regulationTelomere cohesionEmbryonic developmentRegulation of gene expression
04

Disease associations

Cohesinopathies (including developmental syndromes with dysmorphic features and intellectual disability)Cancer (synthetic lethality with STAG2 mutation, especially in leukemia and other solid tumors)Other: implicated by genetic studies in metabolic traits and possible modulation of cellular stress responses
05

Safety considerations

Essential role in cell division/embryonic development—systemic inhibition could cause cytotoxicity or developmental toxicityLoss-of-function mutations linked to developmental disorders and congenital anomalies
06

Interacting drugs

No FDA-approved drugs directly targeting STAG1 as of 2024

1 more in the full profile.

07

Biomarkers

Loss or mutation of STAG1 or STAG2 for patient selection in investigational synthetic lethality approachesExpression or mutation status (as sequenced in cancer and developmental disorders) is used in research contexts

Beyond the preview

Go deeper on Stromal antigen 1 (STAG1) (SA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stromal antigen 1 (STAG1) (SA1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call